Suppr超能文献

糖尿病并发症预防与管理的近期治疗靶点。

Recent therapeutic targets for the prevention and management of diabetic complications.

作者信息

Islam Md Shahidul, Cai Lu, Horowitz Michael

机构信息

Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Durban 4000, KwaZulu-Natal, South Africa.

Pediatric Research Institute, University of Louisville, Louisville, KY 40202, United States.

出版信息

World J Diabetes. 2023 Sep 15;14(9):1330-1333. doi: 10.4239/wjd.v14.i9.1330.

Abstract

Diabetes and associated complications represent major global public health issues which are associated with impaired quality of life and premature death. Although some diabetic complications have decreased in the developed world, the majority are still prevalent, with an increasing trend in the developing world. Currently used therapies are mainly 'glucocentric', focusing on the optimization of glycemic control to prevent, delay or manage diabetes-associated complications- other common comorbidities, such as dyslipidemia and hypertension are often underestimated. Although a number of novel therapeutic approaches have been reported recently, some of them have not received comparable attention in relation to either further studies or potential clinical implementation. This editorial briefly discusses some recent therapeutic approaches to the prevention and management of diabetes and its associated complications, as well as potential directions for future research and development in this area.

摘要

糖尿病及其相关并发症是重大的全球公共卫生问题,与生活质量受损和过早死亡相关。尽管在发达国家一些糖尿病并发症有所减少,但大多数仍普遍存在,且在发展中国家呈上升趋势。目前使用的治疗方法主要以“血糖为中心”,侧重于优化血糖控制以预防、延缓或管理糖尿病相关并发症——其他常见的合并症,如血脂异常和高血压,常常被低估。尽管最近报道了一些新的治疗方法,但其中一些在进一步研究或潜在临床应用方面并未受到同等关注。这篇社论简要讨论了预防和管理糖尿病及其相关并发症的一些最新治疗方法,以及该领域未来研发的潜在方向。

相似文献

1
Recent therapeutic targets for the prevention and management of diabetic complications.
World J Diabetes. 2023 Sep 15;14(9):1330-1333. doi: 10.4239/wjd.v14.i9.1330.
2
as Potential Therapy for Diabetes and Microvascular Complications.
Nutrients. 2023 Apr 23;15(9):2031. doi: 10.3390/nu15092031.
3
Constipation in DM are associated with both poor glycemic control and diabetic complications: Current status and future directions.
Biomed Pharmacother. 2023 Sep;165:115202. doi: 10.1016/j.biopha.2023.115202. Epub 2023 Jul 26.
4
Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
Diabetes Care. 2020 Jul;43(7):1557-1592. doi: 10.2337/dci20-0017.
7
Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control.
Front Physiol. 2018 Oct 30;9:1514. doi: 10.3389/fphys.2018.01514. eCollection 2018.
10
Hydrogen Sulfide in Diabetic Complications Revisited: The State of the Art, Challenges, and Future Directions.
Antioxid Redox Signal. 2023 Jan;38(1-3):18-44. doi: 10.1089/ars.2022.0028.

引用本文的文献

2
Understanding the Clinical Relationship Between Diabetic Retinopathy, Nephropathy, and Neuropathy: A Comprehensive Review.
Cureus. 2024 Mar 21;16(3):e56674. doi: 10.7759/cureus.56674. eCollection 2024 Mar.
3
Potential therapeutic targets for the prevention of diabetic nephropathy: Glycyrrhetinic acid.
World J Diabetes. 2023 Dec 15;14(12):1717-1720. doi: 10.4239/wjd.v14.i12.1717.

本文引用的文献

2
Nanoformulations of flavonoids for diabetes and microvascular diabetic complications.
Drug Deliv Transl Res. 2023 Jan;13(1):18-36. doi: 10.1007/s13346-022-01174-x. Epub 2022 May 30.
3
miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms.
J Physiol Biochem. 2022 Feb;78(1):19-37. doi: 10.1007/s13105-021-00867-0. Epub 2022 Jan 31.
4
Role of miRNAs in diabetic neuropathy: mechanisms and possible interventions.
Mol Neurobiol. 2022 Mar;59(3):1836-1849. doi: 10.1007/s12035-021-02662-w. Epub 2022 Jan 13.
5
Curcumin and Its Analogs as Potential Epigenetic Modulators: Prevention of Diabetes and Its Complications.
Pharmacology. 2022;107(1-2):1-13. doi: 10.1159/000520311. Epub 2021 Dec 15.
6
SIRT1-FOXOs activity regulates diabetic complications.
Pharmacol Res. 2022 Jan;175:106014. doi: 10.1016/j.phrs.2021.106014. Epub 2021 Nov 29.
7
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications.
Lancet. 2021 Jul 17;398(10296):262-276. doi: 10.1016/S0140-6736(21)00536-5. Epub 2021 Jun 30.
8
Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to Correction.
Bull Exp Biol Med. 2021 May;171(2):179-189. doi: 10.1007/s10517-021-05191-7. Epub 2021 Jun 26.
9
Diabetes and zinc dyshomeostasis: Can zinc supplementation mitigate diabetic complications?
Crit Rev Food Sci Nutr. 2022;62(4):1046-1061. doi: 10.1080/10408398.2020.1833178. Epub 2020 Oct 14.
10
SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication.
Front Endocrinol (Lausanne). 2020 Nov 16;11:568861. doi: 10.3389/fendo.2020.568861. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验